Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,270 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Administration of pegylated recombinant human megakaryocyte growth and development factor to humans stimulates the production of functional platelets that show no evidence of in vivo activation.
O'Malley CJ, Rasko JE, Basser RL, McGrath KM, Cebon J, Grigg AP, Hopkins W, Cohen B, O'Byrne J, Green MD, Fox RM, Berndt MC, Begley CG. O'Malley CJ, et al. Among authors: cohen b. Blood. 1996 Nov 1;88(9):3288-98. Blood. 1996. PMID: 8896392 Free article. Clinical Trial.
Randomized, blinded, placebo-controlled phase I trial of pegylated recombinant human megakaryocyte growth and development factor with filgrastim after dose-intensive chemotherapy in patients with advanced cancer.
Basser RL, Rasko JE, Clarke K, Cebon J, Green MD, Grigg AP, Zalcberg J, Cohen B, O'Byrne J, Menchaca DM, Fox RM, Begley CG. Basser RL, et al. Among authors: cohen b. Blood. 1997 May 1;89(9):3118-28. Blood. 1997. PMID: 9129014 Free article. Clinical Trial.
Successful mobilization of peripheral blood stem cells after addition of ancestim (stem cell factor) in patients who had failed a prior mobilization with filgrastim (granulocyte colony-stimulating factor) alone or with chemotherapy plus filgrastim.
To LB, Bashford J, Durrant S, MacMillan J, Schwarer AP, Prince HM, Gibson J, Lewis I, Swart B, Marty J, Rawling T, Ashman L, Charles S, Cohen B. To LB, et al. Among authors: cohen b. Bone Marrow Transplant. 2003 Mar;31(5):371-8. doi: 10.1038/sj.bmt.1703860. Bone Marrow Transplant. 2003. PMID: 12634728 Clinical Trial.
Evaluation of severe rhabdomyolysis on day 30 mortality in trauma patients admitted to intensive care: a propensity score analysis of the Traumabase registry.
Martinez T, Harrois A, Codorniu A, Mongardon N, Pissot M, Popoff B, Leone M, Delhaye N, Vicaut E, Mathais Q, Legros V, Hanouz JL, Gatulle N, Ramonda V, Cohen B, Boutonnet M, Pottecher J, Libert N; Traumabase Group. Martinez T, et al. Among authors: cohen b. Crit Care. 2024 Nov 22;28(1):382. doi: 10.1186/s13054-024-05158-w. Crit Care. 2024. PMID: 39578880 Free PMC article.
4,270 results